Premium
P3–271: Clinical benefits of extended‐release memantine (28 mg, once daily) as a function of disease severity in people with moderate to severe Alzheimer's disease: Post hoc analysis from a randomized trial
Author(s) -
Tocco Michael,
Hendrix Suzanne,
Miller Michael,
Pejovic Vojislav,
Graham Stephen
Publication year - 2013
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2013.05.1345
Subject(s) - memantine , post hoc analysis , placebo , medicine , analysis of variance , alzheimer's disease , psychology , disease , dementia , pathology , alternative medicine